Literature DB >> 24596733

Is there a Need for Luteinizing Hormone (LH) Estimation in Patients Undergoing Ovarian Stimulation with Gonadotropin-Releasing Hormone (GnRH) Antagonists and Recombinant Follicle-Stimulating Hormone (rFSH)?

Amar Ramachandran1, Kshitij Jamdade2, Pratap Kumar3, Satish Kumar Adiga4, Rajeshwari G Bhat1, Sinatra R Ferrao2.   

Abstract

AIM: To find out effect of serum luteinizing hormone (LH) levels on Day 1 (Day 2 of cycle) and Day 5 of stimulation and Day of trigger hCG in controlled ovulation stimulation with antagonist protocol of IVF-ICSI cycle on cycle outcome.
MATERIALS AND METHODS: This retrospective study was conducted in a University Hospital setting. One hundred and 62 patients underwent 165 cycles of controlled ovarian stimulation (COS) with recombinant Follicle stimulating hormone (rFSH) and Gonadotropin releasing hormone (GnRH) antagonist protocol in one year were included. Serum LH levels estimated on Day 1, Day 5 and the day of trigger hCG injections were divided into three groups based on the percentile and outcome measured.
RESULTS: The average number of follicles >18 mm in size were significant in the patients with LH levels between 25th to 75th percentile group on Day 1, Day 5 and Day of trigger hCG. The fertilization rate was significant (p= 0.04) in the patients with LH levels < 25thpercentile on the day of trigger hCG. Oocyte recovery rate, oocyte maturation rate and average number of best quality embryos (Grade 1) were not affected significantly in all three groups.
CONCLUSION: In GnRH antagonist and rFSH protocols, low serum LH concentrations on the day of trigger hCG has better fertilization rate. LH levels between 25th and 75th percentile have an influence on the average number of > 18 mm size follicles. However, the LH level on Day 1, Day 5 and Day of hCG does not affect the cycle outcome in COS with antagonist protocol of IVF cycle. Hence, LH estimation is not mandatory in ART cycles with GnRH antagonist protocol.

Entities:  

Keywords:  Gonadotropin releasing hormone (GnRH) antagonist ligament; Luteinizing hormone; recombinant Follicle stimulating hormone (rFSH)

Year:  2014        PMID: 24596733      PMCID: PMC3939598          DOI: 10.7860/JCDR/2014/5728.3778

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  10 in total

1.  Serum luteinizing hormone in patients undergoing ovarian stimulation with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone and its relationship with cycle outcome.

Authors:  Ernesto Bosch; Ernesto Escudero; Juana Crespo; Carlos Simón; José Remohí; Antonio Pellicer
Journal:  Fertil Steril       Date:  2005-11       Impact factor: 7.329

2.  Location and developmental regulation of androgen receptor in primate ovary.

Authors:  S G Hillier; M Tetsuka; H M Fraser
Journal:  Hum Reprod       Date:  1997-01       Impact factor: 6.918

3.  Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up.

Authors:  Efstratios Kolibianakis; Claire Bourgain; Carola Albano; Kaan Osmanagaoglu; Johan Smitz; Andre Van Steirteghem; Paul Devroey
Journal:  Fertil Steril       Date:  2002-11       Impact factor: 7.329

Review 4.  The neuroendocrine control of the menstrual cycle.

Authors:  E Knobil
Journal:  Recent Prog Horm Res       Date:  1980

5.  In vitro fertilization outcomes in patients experiencing a premature rise in luteinizing hormone during a gonadotropin-releasing hormone antagonist cycle.

Authors:  Nicole E Kummer; Vanessa N Weitzman; Claudio A Benadiva; David W Schmidt; Lawrence L Engmann; John C Nulsen
Journal:  Fertil Steril       Date:  2011-02-03       Impact factor: 7.329

6.  Optimizing GnRH antagonist administration: meta-analysis of fixed versus flexible protocol.

Authors:  Hesham Al-Inany; Mohamed A Aboulghar; Ragaa T Mansour; Gamal I Serour
Journal:  Reprod Biomed Online       Date:  2005-05       Impact factor: 3.828

7.  Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome.

Authors:  Ernesto Bosch; Iván Valencia; Ernesto Escudero; Juana Crespo; Carlos Simón; José Remohí; Antonio Pellicer
Journal:  Fertil Steril       Date:  2003-12       Impact factor: 7.329

8.  Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy.

Authors:  Efstratios M Kolibianakis; Carola Albano; Jarl Kahn; Michel Camus; Herman Tournaye; Andre C Van Steirteghem; Paul Devroey
Journal:  Fertil Steril       Date:  2003-04       Impact factor: 7.329

9.  Luteinizing hormone concentrations after gonadotropin-releasing hormone antagonist administration do not influence pregnancy rates in in vitro fertilization-embryo transfer.

Authors:  Philippe Merviel; Jean-Marie Antoine; Emmanuelle Mathieu; Françoise Millot; Jacqueline Mandelbaum; Serge Uzan
Journal:  Fertil Steril       Date:  2004-07       Impact factor: 7.329

10.  Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation.

Authors:  K Diedrich; C Diedrich; E Santos; C Zoll; S al-Hasani; T Reissmann; D Krebs; D Klingmüller
Journal:  Hum Reprod       Date:  1994-05       Impact factor: 6.918

  10 in total
  5 in total

1.  [Effects of luteinizing hormone supplementation on outcomes of in vitro fertilization and embryo transfer in patients undergoing GnRH-agonist long protocol].

Authors:  Yu Deng; Min-Na Yin; Pei-Ling Liang; Zhi-Heng Chen; Ling Sun
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-11-20

2.  Is there a relationship between luteinizing hormone levels and ART outcome in GnRH antagonist protocols? A retrospective cross-sectional study.

Authors:  Maryam Eftekhar; Masrooreh Hoseini; Nasim Tabibnejad
Journal:  Indian J Endocrinol Metab       Date:  2022-02-17

3.  The Effect of Luteinising Hormone Suppression in In Vitro Fertilisation Antagonist Cycles.

Authors:  Jody Paige Goh; Jill Cheng Sim Lee; Jerry Kok Yen Chan; John Carson Allen; Xiang Wen Ng; Sadhana Nadarajah; Jessie Wai Leng Phoon; Shuling Liu
Journal:  Reprod Sci       Date:  2021-06-02       Impact factor: 2.924

4.  Ovarian stimulation with human and recombinant gonadotropin - comparison of in vitro fertilization efficiency with use of time-lapse monitoring.

Authors:  Artur Wdowiak; Iwona Bojar
Journal:  Reprod Health       Date:  2015-12-15       Impact factor: 3.223

5.  Interactions of Cortisol and Prolactin with Other Selected Menstrual Cycle Hormones Affecting the Chances of Conception in Infertile Women.

Authors:  Artur Wdowiak; Dorota Raczkiewicz; Paula Janczyk; Iwona Bojar; Marta Makara-Studzińska; Anita Wdowiak-Filip
Journal:  Int J Environ Res Public Health       Date:  2020-10-16       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.